abs271.txt	the	aim	of	this	study	was	to	develop	a	new	drug	substance	with	low	toxicity	andeffective	inhibitory	activity	against	cisplatin-resistant	oral	cancer		thenaturally	produced	pterostilbene	selected	as	lead	compound	for	design	andsynthesis	series	bis(hydroxymethyl)propionate-based	prodrugs	allderivatives	were	screened	antiproliferative	effects	thecisplatin-resistant	squamous	(car)	cell	line	and	results	indicated	thatseveral	compounds	demonstrated	superior	compared	withpterostilbene	resveratrol	among	them	most	promising	12	wasevaluated	in	vivo	antitumor	car	xenograft	nude	mouse	model	obvious	observed	at	lowest	dose	(25	mg/kg/day)	increasing	100	mg/kg/day	reduced	tumor	size	22%	thecontrol	group	based	on	these	findings	well	extremely	seenin	studies	we	believe	that	could	serve	forfurther	development
